{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:03:51Z","timestamp":1790154231989,"version":"4.0.1"},"reference-count":60,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Centre of Postgraduate Medical Education, Warsaw, Poland","award":["501-1-025-01-25\/MG7"],"award-info":[{"award-number":["501-1-025-01-25\/MG7"]}]},{"award":["501-1-025-01-25\/MG7"],"award-info":[{"award-number":["501-1-025-01-25\/MG7"]}],"id":[{"id":"https:\/\/ror.org\/01cx2sj34","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Primary biliary cholangitis (PBC) is a chronic autoimmune, cholestatic liver disease leading to fibrosis, cirrhosis, and portal hypertension. Endothelin-1 (ET-1), a potent vasoconstrictor with profibrotic properties, has been implicated in the pathogenesis of liver fibrosis and portal hypertension. Anti-cardiolipin antibodies (aCL) may further contribute to disease progression by promoting thrombotic complications. Our aim was to evaluate serum ET-1 concentrations and anti-cardiolipin antibody levels in PBC patients and their association with portal hypertension. Serum samples from 80 patients with PBC, including patients with portal hypertension, and 25 healthy controls were analyzed. ET-1 concentrations and anti-cardiolipin antibodies were measured using commercially available immunoassays. Elevated serum ET-1 levels were detected in 84% of patients with PBC and portal hypertension and the ET-1 concentrations were also significantly higher in this group compared to the control group. Serum ET-1 levels positively correlated with total bilirubin concentrations and the severity of histological fibrosis. Anti-cardiolipin antibodies were detected in 32% of PBC patients with portal hypertension. Elevated serum ET-1 concentrations and the presence of anti-cardiolipin antibodies are associated with advanced liver disease and portal hypertension in patients with PBC. These biomarkers may have potential value in identifying patients at increased risk of disease progression and worsening liver function.<\/jats:p>","DOI":"10.3390\/ijms27198461","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:14:39Z","timestamp":1790151279000},"page":"8461","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Endothelin-1 and Anticardiolipin Antibodies in Primary Biliary Cholangitis Patients with Portal Hypertension: A Pilot Retrospective Study"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2051-1177","authenticated-orcid":false,"given":"Alicja","family":"Bauer","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Centre of Postgraduate Medical Education, Marymoncka 99\/103, 01-813 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Rawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Hepatology and Clinical Oncology, Centre of Postgraduate Medical Education, Roentgena 5, 02-781 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5899-7454","authenticated-orcid":false,"given":"Tomasz","family":"Bauer","sequence":"additional","affiliation":[{"name":"Faculty of Chemistry, University of Warsaw, L. Pasteura 1, 02-093 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref_1","first-page":"e0179","article-title":"Primary biliary cholangitis: Epidemiology, prognosis, and treatment","volume":"2","author":"Trivella","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-021-10276-6","article-title":"APASL Clinical Practice Guidance: The Diagnosis and Management of Patients with Primary Biliary Cholangitis","volume":"16","author":"You","year":"2022","journal-title":"Hepatol. Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1515\/cclm-2023-0742","article-title":"Diagnostic and prognostic value of quantitative detection of antimitochondrial antibodies subtype M2 using chemiluminescence immunoassay in primary biliary cholangitis","volume":"62","author":"Wang","year":"2023","journal-title":"CCLM"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13223-021-00539-0","article-title":"Autoantibodies to Speckled Protein Family in Primary Biliary Cholangitis","volume":"17","author":"Granito","year":"2021","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e1161","DOI":"10.1002\/iid3.1161","article-title":"Clinical performance of AMA-M2, anti-gp210 and anti-sp100 antibody levels in primary biliary cholangitis: When detected by multiplex bead-based flow fluorescent immunoassay","volume":"12","author":"Wang","year":"2024","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e36039","DOI":"10.1097\/MD.0000000000036039","article-title":"Diagnostic value of anti-mitochondrial antibody in patients with primary biliary cholangitis: A systemic review and meta-analysis","volume":"102","author":"Xu","year":"2023","journal-title":"Medicine"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bauer, A., Habior, A., Wieszczy, P., and Gawel, D. (2021). Analysis of Autoantibodies against Promyelocytic Leukemia Nuclear Body Components and Biochemical Parameters in Sera of Patients with Primary Biliary Cholangitis. Diagnostics, 24.","DOI":"10.3390\/diagnostics11040587"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/s13075-023-03163-y","article-title":"Integrative bioinformatics analysis and experimental validation of key biomarkers for risk stratification in primary biliary cholangitis","volume":"25","author":"Tian","year":"2023","journal-title":"Arthritis Res. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Arnaldos-P\u00e9rez, C., P\u00e9rez-Isidro, A., Bolos, U., Dom\u00e8nech, C., Ball\u00fas, J., Rodr\u00edguez-Tajes, S., Londo\u00f1o, M.C., Vi\u00f1as, O., and Ruiz-Ortiz, E. (2023). Detection of M2-Type Anti-Mitochondrial Autoantibodies against Specific Subunits in the Diagnosis of Primary Biliary Cholangitis in Patients with Discordant Results. Diagnostics, 13.","DOI":"10.3390\/diagnostics13111840"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.cca.2014.08.024","article-title":"Autoantibody profiling of patients with primary biliary cirrhosis using a multiplexed line-blot assay","volume":"438","author":"Villalta","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.phrs.2011.01.002","article-title":"Endothelins and their receptors in cancer: Identification of therapeutic targets","volume":"63","author":"Wang","year":"2011","journal-title":"Pharmacol. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"9121207","DOI":"10.1155\/2019\/9121207","article-title":"Early Prognostic Utility of Gp210 Antibody-Positive Rate in Primary Biliary Cholangitis: A Meta-Analysis","volume":"2019","author":"Huang","year":"2019","journal-title":"Dis. Markers"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/jcla.20170","article-title":"Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis","volume":"21","author":"Bauer","year":"2007","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.clinre.2013.10.008","article-title":"Autoantibodies in primary biliary cirrhosis: Antinuclear envelope autoantibodies","volume":"38","author":"Chantran","year":"2014","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1515\/cclm-2017-0249","article-title":"The diagnostic accuracy of biomarkers for diagnosis of primary biliary cholangitis (PBC) in anti-mitochondrial antibody (AMA)-negative PBC patients: A review of literature","volume":"56","author":"Matinato","year":"2017","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Hu, S.-L., Zhao, F.-R., Hu, Q., and Chen, W.-X. (2014). Meta-Analysis Assessment of GP210 and SP100 for the Diagnosis of Primary Biliary Cirrhosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101916"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"8959103","DOI":"10.1155\/2019\/8959103","article-title":"Meta-Analysis of Antinuclear Antibodies in the Diagnosis of Antimitochondrial Antibody-Negative Primary Biliary Cholangitis","volume":"2019","author":"Zhang","year":"2019","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bauer, A., Habior, A., and Gawel, D. (2022). Diagnostic and Clinical Value of Specific Autoantibodies against Kelch-like 12 Peptide and Nuclear Envelope Proteins in Patients with Primary Biliary Cholangitis. Biomedicines, 10.","DOI":"10.3390\/biomedicines10040801"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zhong, H., Zheng, M., Zhao, C., Wei, Q., Ou, Z., Wang, T., Li, N., Shi, Z., Li, S., and Yao, Y. (2026). Primary biliary cholangitis with inflammation involving zone 3 of the liver has a poor response to ursodeoxycholic acid treatment: A retrospective cohort study. BMC Gastroenterol., 26.","DOI":"10.1186\/s12876-026-04665-0"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1097\/MEG.0000000000002033","article-title":"Portal hypertension in primary biliary cholangitis: Prevalence, natural history and histological correlates","volume":"33","author":"Warnes","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1177\/1535370220949148","article-title":"Endothelin-1 in portal hypertension: The intricate role of hepatic stellate cells","volume":"245","author":"Ezhilarasan","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.11613\/BM.2011.032","article-title":"Endothelins-clinical perspectives","volume":"21","author":"Unic","year":"2011","journal-title":"Biochem. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1161\/HYPERTENSIONAHA.119.12105","article-title":"Endothelin: 30 Years from Discovery to Therapy","volume":"74","author":"Barton","year":"2019","journal-title":"Hypertension"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/332411a0","article-title":"A novel potent vasoconstrictor peptide produced by vascular endothelial cells","volume":"332","author":"Yanagisawa","year":"1988","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1038\/nrc3546","article-title":"Endothelin 1 in cancer: Biological implications and therapeutic opportunities","volume":"13","author":"Rosano","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Banecki, K., and Dora, K.A. (2023). Endothelin-1 in Health and Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411295"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e014-2026","DOI":"10.1152\/function.014.2026","article-title":"Role for endothelin-1 in cardiometabolic dysfunction with intermittent hypoxia","volume":"7","author":"Gonsalves","year":"2026","journal-title":"Function"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1089\/ham.2005.6.112","article-title":"Cellular and molecular mechanisms associated with carotid body adaptations to chronic hypoxia","volume":"6","author":"Prabhakar","year":"2005","journal-title":"High Alt. Med. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"42","DOI":"10.18359\/rmed.1179","article-title":"Endothelin-1: Intrinsic vasoconstrictor vascular endothelial","volume":"21","year":"2013","journal-title":"Rev. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Pulito-Cueto, V., Genre, F., L\u00f3pez-Mej\u00edas, R., Mora-Cuesta, V.M., Iturbe-Fern\u00e1ndez, D., Portilla, V., Sebasti\u00e1n Mora-Gil, M., Ocejo-Vinyals, J.G., Gualillo, O., and Blanco, R. (2023). Endothelin-1 as a Biomarker of Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Associated with Autoimmune Diseases. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24021275"},{"key":"ref_31","unstructured":"Titus, A., and Marappa-Ganeshan, R. (2023, May 01). Physiology, Endothelin, StatPearls [Internet], Available online: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551627\/."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"e13086","DOI":"10.1111\/obr.13086","article-title":"Endothelin-1 in the pathophysiology of obesity and insulin resistance","volume":"21","author":"Jenkins","year":"2020","journal-title":"Obes. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"iii8","DOI":"10.1093\/rheumatology\/kel294","article-title":"The role of endothelin in connective tissue diseases","volume":"45","author":"Sticherling","year":"2006","journal-title":"Rheumatology"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1165\/rcmb.2009-0175TR","article-title":"Potential role of endothelin-1 in pulmonary fibrosis: From the bench to the clinic","volume":"42","author":"Ross","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2165\/11319550-000000000-00000","article-title":"The role of endothelin-1 in the pathogenesis of idiopathic pulmonary fibrosis","volume":"24","author":"Swigris","year":"2010","journal-title":"BioDrugs"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"v25","DOI":"10.1093\/rheumatology\/ken283","article-title":"Endothelin and scleroderma lung disease","volume":"47","author":"Silver","year":"2008","journal-title":"Rheumatology"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10067-004-0987-3","article-title":"Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: Relationship to organ systemic involvement","volume":"24","author":"Klimiuk","year":"2005","journal-title":"Clin. Rheumatol."},{"key":"ref_38","first-page":"63","article-title":"Levels of circulating endothelin-1 and nitrates\/nitrites in patients with virus-related hepatocellular carcinoma","volume":"8","author":"Notas","year":"2001","journal-title":"J. Viral Hepat."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"17534666231223606","DOI":"10.1177\/17534666231223606","article-title":"Liver injury due to endothelin receptor antagonists: A real-world study based on post-marketing drug monitoring data","volume":"18","author":"Dong","year":"2024","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s43066-020-00030-2","article-title":"Diagnostic accuracy of serum endothelin-1 in patients with HCC on top of liver cirrhosis","volume":"10","author":"Elbadry","year":"2020","journal-title":"Egypt. Liver J."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1111\/j.1572-0241.1999.01447.x","article-title":"Anticardiolipin antibodies in patients with liver disease","volume":"94","author":"Mangia","year":"1999","journal-title":"Am. J. Gastroenterol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1468-1331.1998.530287.x","article-title":"Prevalence of high IgM anticardiolipins in patients with ischemic stroke","volume":"5","author":"Szczepanski","year":"1998","journal-title":"Eur. J. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0020-7292(98)00007-1","article-title":"Antiphospholipid antibodies and lipoprotein (a) in women with recurrent fetal loss","volume":"61","author":"Bauer","year":"1998","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clim.2006.01.002","article-title":"Presence of high avidity anticardiolipin antibodies in patients with autoimmune cholestatic liver diseases","volume":"119","author":"Zachou","year":"2006","journal-title":"Clin. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jcla.21723","article-title":"High frequency of antiphospholipid antibodies in primary biliary cirrhosis","volume":"29","author":"Manoubi","year":"2015","journal-title":"J. Clin. Lab. Anal."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.phrs.2011.03.005","article-title":"Endothelin and hepatic wound healing","volume":"63","author":"Khimji","year":"2011","journal-title":"Pharmacol. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jhep.2025.10.017","article-title":"The role of liver sinusoidal endothelial cells in liver diseases: Key players in health and pathology","volume":"84","author":"Felli","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12072-017-9826-x","article-title":"Biology of portal hypertension","volume":"12","author":"McConnell","year":"2018","journal-title":"Hepatol. Int."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/poh2.17","article-title":"Endothelins and liver cirrhosis","volume":"1","year":"2022","journal-title":"Potal Hypertens. Cirrhosis"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1152\/physrev.00027.2008","article-title":"The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair","volume":"89","author":"Vollmar","year":"2009","journal-title":"Physiol. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"100197","DOI":"10.1016\/j.iliver.2025.100197","article-title":"From thrombosis to transplantation: The role of anti-phospholipid antibodies in liver disease management","volume":"4","author":"Pallotta","year":"2025","journal-title":"iLIVER"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/hepr.12585","article-title":"Serum levels of endothelin-1 after liver resection as an early predictor of postoperative liver failure. A prospective study","volume":"46","author":"Ratti","year":"2016","journal-title":"Hepatol. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.jhep.2014.05.047","article-title":"Vascular pathobiology in chronic liver disease and cirrhosis\u2014Current status and future directions","volume":"61","author":"Iwakiri","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1002\/1529-0131(199805)41:5<800::AID-ART5>3.0.CO;2-J","article-title":"Arterial disease and thrombosis in the antiphospholipid syndrome: A pathogenic role for endothelin 1","volume":"41","author":"Atsumi","year":"1998","journal-title":"Arthritis Rheum."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Yang, L., Guo, R., Liu, H., Chen, B., Li, C., Liu, R., Liao, S., Xie, Q., and Yin, G. (2025). Mechanism of antiphospholipid antibody-mediated thrombosis in antiphospholipid syndrome. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1527554"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00281-022-00916-w","article-title":"Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome","volume":"44","author":"Knight","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Avram, R.I., Minea, H.O., Huiban, L., Damian, I.R., Muset, M.C., Juncu, S., Muzica, C.M., Zenovia, S., Singeap, A.M., and Girleanu, I. (2025). Advancements in Beta-Adrenergic Therapy and Novel Personalised Approach for Portal Hypertension: A Narrative Review. Life, 24.","DOI":"10.3390\/life15081173"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4149\/gpb_2012_046","article-title":"The role of endothelin-1 and its receptor blockers on the liver function","volume":"31","author":"Michalski","year":"2012","journal-title":"Gen. Physiol. Biophys."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"45417","DOI":"10.31083\/RCM45417","article-title":"Endothelin as a Treatment Target in Cardiovascular Diseases: A Recent Step Forward","volume":"26","author":"Cole","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2017). EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. J. Hepatol., 67, 145\u2013172.","DOI":"10.1016\/j.jhep.2017.03.022"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8461\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:17:15Z","timestamp":1790151435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":60,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198461"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198461","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}